BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23259566)

  • 1. Lessons from the REACH Registry in Europe.
    Valentijn TM; Stolker RJ
    Curr Vasc Pharmacol; 2012 Nov; 10(6):725-7. PubMed ID: 23259566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
    Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
    Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cacoub PP; Abola MT; Baumgartner I; Bhatt DL; Creager MA; Liau CS; Goto S; Röther J; Steg PG; Hirsch AT;
    Atherosclerosis; 2009 Jun; 204(2):e86-92. PubMed ID: 19054514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease.
    Alvarez LR; Balibrea JM; Suriñach JM; Coll R; Pascual MT; Toril J; López-Jiménez L; Monreal M;
    Eur J Prev Cardiol; 2013 Jun; 20(3):486-95. PubMed ID: 21968571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease.
    van Kuijk JP; Flu WJ; Welten GM; Hoeks SE; Chonchol M; Vidakovic R; Verhagen HJ; Bax JJ; Poldermans D
    Eur Heart J; 2010 Apr; 31(8):992-9. PubMed ID: 20037181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
    Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
    Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvascular Disease: Reappraisal of the Current Clinical Landscape.
    Gutierrez JA; Aday AW; Patel MR; Jones WS
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e007385. PubMed ID: 31833412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention.
    Pereg D; Elis A; Neuman Y; Mosseri M; Segev D; Granek-Catarivas M; Lishner M; Hermoni D
    Coron Artery Dis; 2014 Jan; 25(1):79-82. PubMed ID: 24128887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.
    Parhofer KG; Zeymer U; Stark RG; Binz C; Schwertfeger M; Bhatt DL; Steg PG; Röther J;
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):51-6. PubMed ID: 19834877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.
    Reid CM; Ademi Z; Nelson MR; Connor G; Chew DP; Shiel L; Smeath A; De Looze F; Steg PG; Bhatt DL; Liew D;
    Med J Aust; 2012 Feb; 196(3):193-7. PubMed ID: 22339526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries.
    Mukherjee D; Eagle K
    Curr Vasc Pharmacol; 2010 May; 8(3):293-300. PubMed ID: 19758116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.
    Bauersachs R; Zeymer U; Brière JB; Marre C; Bowrin K; Huelsebeck M
    Cardiovasc Ther; 2019; 2019():8295054. PubMed ID: 32099582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.
    Yeo TC; Chan YH; Low LP; Venketasubramanian N; Lim SC; Tay JC; Tan RS; Eng P; Lingamanaicker J;
    Ann Acad Med Singap; 2008 May; 37(5):365-71. PubMed ID: 18536821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.
    Suárez C; Zeymer U; Limbourg T; Baumgartner I; Cacoub P; Poldermans D; Röther J; Bhatt DL; Steg PG;
    Vasc Med; 2010 Aug; 15(4):259-65. PubMed ID: 20724374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease.
    Smolderen KG; Wang K; de Pouvourville G; Brüggenjürgen B; Röther J; Zeymer U; Parhofer KG; Steg PG; Bhatt DL; Magnuson EA;
    Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):198-207. PubMed ID: 22001145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.